Malignant melanoma of the nasal cavity treated with stereotactic radiotherapy using CyberKnife: report of 2 cases

Takanori Abe; Takeshi Ebara; Kazunori Miyaura; Yu Kumazaki; Mitsuhiko Nakahira; Masashi Sugasawa; Naoto Shikama; Shingo Kato

doi:10.1016/j.amjoto.2014.11.010

Malignant melanoma of the nasal cavity treated with stereotactic radiotherapy using CyberKnife: report of 2 cases

Am J Otolaryngol. 2015 Mar-Apr;36(2):306-9. doi: 10.1016/j.amjoto.2014.11.010. Epub 2014 Dec 2.

Authors

Takanori Abe¹, Takeshi Ebara², Kazunori Miyaura³, Yu Kumazaki³, Mitsuhiko Nakahira⁴, Masashi Sugasawa⁴, Naoto Shikama³, Shingo Kato³

Affiliations

¹ Department of Radiation Oncology, Saitama Medical University, International Medical Center, Hidaka, Japan. Electronic address: mrtaka100@yahoo.co.jp.
² Gunma Prefectural Cancer Center, Ohta, Japan.
³ Department of Radiation Oncology, Saitama Medical University, International Medical Center, Hidaka, Japan.
⁴ Department of Otolaryngology, Saitama Medical University, International Medical Center, Hidaka, Japan.

PMID: 25510209
DOI: 10.1016/j.amjoto.2014.11.010

Abstract

Radiotherapy with high doses per fraction may have the potential to control radioresistant tumors, such as malignant melanoma. Here we report 2 cases with malignant melanoma of the nasal cavity treated with hypofractionated stereotactic radiotherapy using CyberKnife®.

Publication types

Review

MeSH terms

Aged
Chemotherapy, Adjuvant
Follow-Up Studies
Humans
Lymph Nodes / pathology*
Male
Melanoma / diagnosis
Melanoma / drug therapy
Melanoma / surgery*
Middle Aged
Nasal Cavity / pathology
Nasal Cavity / surgery*
Neck Dissection / methods
Neoplasm Invasiveness / pathology
Neoplasm Staging
Nose Neoplasms / diagnosis
Nose Neoplasms / drug therapy
Nose Neoplasms / surgery*
Positron-Emission Tomography / methods
Radiosurgery / methods*
Risk Assessment
Sampling Studies
Time Factors
Tomography, X-Ray Computed / methods
Treatment Outcome